TP53 and endometrial cancer: Mhawech-Fauceglia et al. [126] detected the expression of DNA repair protein in 357 cases of endometrial cancer via tissue microarray and found that patients characterized by ATM (+) and p53 (+) or FANCD2 (+) had a remarkably higher risks of recurrence compared with other patients, with a 5-year RFS rate of 80.3%.